Staphylococcus aureus
Use of Dalbavancin in Optimizing the Management of ABSSSIs in Patients With Obesity or Diabetes
This Special Report reviews data on the use of dalbavancin for the treatment of ABSSSIs to support safety and ...
JULY 9, 2024
Deadly Staph Infections Remain Threat in Hospitals and Communities
MRSA bloodstream infections in health care settings decreased about 17% each year between 2005 and 2012, but the ...
MARCH 5, 2019
FDA Clears T2Bacteria Panel for Detecting Sepsis-Causing Pathogens
Sepsis affects 1.6 million U.S. patients each year, resulting in more than 250,000 deaths.
JUNE 2, 2018
Load more